Real-world data and practice observations provide further insight into the effective use of the JAK inhibitor in moderate-to-severe ulcerative colitis.
Symptomatic strictures related to Crohn s disease may respond to immunosuppressive drug therapy, with improvements in symptoms and stricture morphology, according to results of a study from Australia.
Many US clinicians who treat for multiple sclerosis adjusted drug regimens during the pandemic s early months to lower risk for COVID-19 infection but they didn t need to, experts say.
A new indirect comparison of three new FDA-approved treatment options for aquaporin4+ neuromyelitis optica has suggested that eculizumab is the most effective. But many limitations have been raised.
The first European consensus on vaccination in patients with MS has been developed by the European Committee for Treatment and Research in Multiple Sclerosis and the European Academy of Neurology.